Mobia Medical, Inc. Common Stock (MOBI) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Mobia Medical, Inc. Common Stock (MOBI) has a cash flow conversion efficiency ratio of 0.106x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-17.73 Million) by net assets ($-167.75 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see market cap of Mobia Medical, Inc. Common Stock for the company's overall valuation and market capitalisation.
Mobia Medical, Inc. Common Stock - Cash Flow Conversion Efficiency Trend (2024–2025)
This chart illustrates how Mobia Medical, Inc. Common Stock's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Mobia Medical, Inc. Common Stock Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Mobia Medical, Inc. Common Stock ranked by their cash flow conversion efficiency. See MOBI operating cash flow to total debt to evaluate how effectively operating cash flow covers total debt obligations.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Viking Line Abp
HE:VIK1V
|
0.151x |
|
RCE Capital Berhad
KLSE:9296
|
0.045x |
|
Irani Papel e Embalagem S.A
SA:RANI3
|
0.113x |
|
QC Solar (Suzhou) Co. Ltd. A
SHE:301278
|
0.010x |
|
Southern States Bancshares Inc
NASDAQ:SSBK
|
0.033x |
|
Immobiliere Dassault SA
PA:IMDA
|
0.022x |
|
TCI Co Ltd
TWO:8436
|
0.034x |
|
Marcopolo S.A
SA:POMO3
|
0.205x |
Annual Cash Flow Conversion Efficiency for Mobia Medical, Inc. Common Stock (2024–2025)
The table below shows the annual cash flow conversion efficiency of Mobia Medical, Inc. Common Stock from 2024 to 2025. View Mobia Medical, Inc. Common Stock (MOBI) stock price for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | $-150.77 Million | $-45.69 Million | 0.303x | +32.16% |
| 2024-12-31 | $-106.04 Million | $-24.32 Million | 0.229x | -- |
About Mobia Medical, Inc. Common Stock
Mobia Medical, Inc. develops and commercializes neurostimulation medical devices, including implantable systems for stroke rehabilitation and other neurological conditions. The company provides neurostimulation systems and devices that combine vagus nerve stimulation with therapy to address chronic neurological conditions. Its main product, the Vivistim System, is an FDA-approved implantable devi… Read more